NRC Files 8-K on Financials and Operations
Ticker: NRC · Form: 8-K · Filed: Jan 27, 2025 · CIK: 70487
| Field | Detail |
|---|---|
| Company | National Research CORP (NRC) |
| Form Type | 8-K |
| Filed Date | Jan 27, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, disclosure
TL;DR
NRC dropped an 8-K detailing financials and operations as of Jan 27, 2025.
AI Summary
National Research Corporation (NRC) filed an 8-K on January 27, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. NRC is incorporated in Delaware and its principal executive offices are located at 1245 Q Street, Lincoln, Nebraska.
Why It Matters
This filing provides investors with crucial updates on National Research Corporation's financial performance and operational status, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial and operational information, not indicating any immediate or significant risks.
Key Players & Entities
- National Research Corporation (company) — Registrant
- 0001437749-25-001928 (accession_number) — Filing identifier
- January 27, 2025 (date) — Report date
- Delaware (jurisdiction) — State of incorporation
- 1245 Q Street, Lincoln, Nebraska 68508 (address) — Principal executive offices
- 4024752525 (phone_number) — Business phone
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on National Research Corporation's results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on January 27, 2025.
Where are National Research Corporation's principal executive offices located?
National Research Corporation's principal executive offices are located at 1245 Q Street, Lincoln, Nebraska 68508.
What is the state of incorporation for National Research Corporation?
National Research Corporation is incorporated in Delaware.
What is the telephone number for National Research Corporation?
The telephone number for National Research Corporation is (402) 475-2525.
Filing Stats: 671 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2025-01-27 17:19:24
Filing Documents
- nrc20250124_8k.htm (8-K) — 31KB
- ex_770300.htm (EX-99.1) — 147KB
- logo.jpg (GRAPHIC) — 14KB
- 0001437749-25-001928.txt ( ) — 335KB
- nrc-20250127.xsd (EX-101.SCH) — 3KB
- nrc-20250127_def.xml (EX-101.DEF) — 11KB
- nrc-20250127_lab.xml (EX-101.LAB) — 15KB
- nrc-20250127_pre.xml (EX-101.PRE) — 11KB
- nrc20250124_8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On January 27, 2025, National Research Corporation, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the fourth quarter and year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.
01
Item 7.01 Regulation FD Disclosure. Chrisophe Louvion, the Company's Chief Product Technology Officer, has resigned.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER EXHIBIT DESCRIPTION 99.1 National Research Corporation press release announcing its financial and operating results for the fourth quarter and year ended December 31, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). The information contained in Items 2.02, 7.01, and 9.01 of this report and the exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information in Items 2.02 and 9.01 of this report and the exhibits hereto may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements are made based on the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results or events may differ from those anticipated by forward-looking statements. Please refer to the paragraph at the end of the attached press release and various disclosures by the Company in its press releases, stockholder reports, and filings with the Securities and Exchange Commission for information concerning risks, uncertainties, and other factors that may affect future results. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL RESEARCH CORPORATION (Registrant) Date: January 27, 2025 By: /s/ Michael D. Hays Michael D. Hays Chief